PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies (Q38647162)

5 September 2017

title

PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies (English)

1 reference

5 September 2017

1 reference

Jamie Garside

1 reference

5 September 2017

Nollaig Healy

1 reference

5 September 2017

Hervé Besson

1 reference

5 September 2017

Ruben Hermans

1 reference

5 September 2017

Finlay MacDougall

1 reference

5 September 2017

Damien Lestelle

1 reference

5 September 2017

Joris Diels

1 reference

5 September 2017

Wafae Iraqi

1 reference

5 September 2017

publication date

2 August 2017

1 reference

Journal of Comparative Effectiveness Research

5 September 2017

published in

1 reference

Randomized controlled trials and comparative effectiveness research

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Design of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Real world data: Additional source for making clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Finding the Evidence in Real-World Evidence: Moving from Data to Information to Knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Marginal structural models and causal inference in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2017-0046

21 January 2018

Identifiers

DOI

10.2217/CER-2017-0046

1 reference

5 September 2017

1 reference